Brunel et al. found that the 6-month cumulative incidence of invasive mold infections for patients, carrying two copies of the minor allele of PTX3 SNPs rs2305619 and/or rs3816527, who had acute myeloid leukemia, acute lymphoblastic leukemia, or refractory anemia with excess blasts-2 and received intense chemotherapy, was significantly different from those without these single SNPs (21% vs 10%; log-rank test p=0.04) in the Lausanne University Hospital 13. The gene discussed is PTX3; the disease is acute myeloid leukemia.